| 翻訳と辞書 |
| China National Pharmaceutical Group Corporation ： ウィキペディア英語版 |
Sinopharm
Sinopharm Group Company Limited () is the largest pharmaceutical company in China, jointly owned by China National Pharmaceutical Group Corporation and Shanghai Fosun Pharmaceutical. Its revenue in 2007 reached 35 billion RMB ($570 million USD).〔http://finance1.jrj.com.cn/news/2008-06-07/000003735074_001.html 国药再谋医药重组央企一哥〕〔(China's Sinopharm gets OK for $1 bln HK IPO )〕
Sinopharm Group researches and develops, manufactures, distributes, and markets medicine and other healthcare products. Sinopharm Group manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China. It also has 10 subsidiaries and a number of major joint ventures. The company also runs about a dozen retail pharmacy chains. Sinopharm Group, which has operations in Africa, France, Germany, Hong Kong, the US, and Vietnam, was formed in 1998.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share.
==See also==
*Pharmaceutical industry in China
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Sinopharm」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|